ZB001 for the Treatment of Thyroid Eye Disease
Thyroid eye disease (TED), also known as Graves ophthalmopathy, is an autoimmune disorder that affects the eyes and is associated with hyperthyroidism.
ZB001
ZB001 also known as the “miracle drug,” is a new breakthrough in the world of medicine. It is an experimental medication that has shown remarkable efficacy against a wide range of viruses, including influenza, HIV, and coronaviruses such as SARS-CoV-2.
ZB002 and ZB004
ZB002 and ZB004 are two different strains of coronavirus that have caused concern and attracted the attention of health officials worldwide. These strains are closely related to the original COVID-19 virus, but they have a few mutations that make them potentially more infectious or resistant to current treatments and vaccines.
Obexelimab and What it Means for Autoimmune Disorders?
Obexelimab is a novel monoclonal antibody that is currently under investigation for the treatment of various autoimmune disorders. This medication works by binding to a protein called CD6, which is found on the surface of T cells in the immune system.